Haemonetics Corporation (HAE)

Operating return on assets (Operating ROA)

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating income	US$ in thousands	221,817	164,883	156,033	80,750	57,963
Total assets	US$ in thousands	2,450,950	2,195,590	1,934,820	1,859,730	1,819,920
Operating ROA		9.05%	7.51%	8.06%	4.34%	3.18%

March 31, 2025 calculation

Operating ROA = Operating income ÷ Total assets
= $221,817K ÷ $2,450,950K
= 9.05%

Haemonetics Corporation's operating return on assets (ROA) has shown a positive trend over the years, increasing from 3.18% as of March 31, 2021, to 7.51% as of March 31, 2024. This indicates that the company has been generating more operating income relative to its total assets, which is a positive sign of operational efficiency and profitability.

However, it's worth noting that the ROA data for March 31, 2025, is not available, so it's difficult to assess the latest performance based on this metric alone. Overall, the increasing trend in operating ROA suggests that Haemonetics has been effectively utilizing its assets to generate operating income, which is a key indicator of the company's financial health and performance.